Skip to content

Transcranial Magnetic Stimulation in Laryngeal Dystonia

Transcranial Magnetic Stimulation in Laryngeal Dystonia

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07683767
Enrollment
20
Registered
2026-07-06
Start date
2026-06-01
Completion date
2027-02-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Dystonia, Spasmodic Dysphonia

Keywords

Repetitive transcranial magnetic stimulation, Neuromodulation, Vocal quality

Brief summary

This randomized clinical trial with a crossover design aims to investigate the effects of neuromodulation through repetitive transcranial magnetic stimulation (rTMS) applied to patients diagnosed with laryngeal dystonia. Participants will undergo three experimental conditions: (1) rTMS alone, (2) rTMS combined with speech-language therapy, and (3) sham rTMS combined with speech-language therapy. The order of the conditions will be randomized. Each phase of the protocol will consist of five consecutive sessions. Outcomes will include acoustic vocal quality parameters, perceptual-auditory voice assessment, self-ratings of vocal effort, smoothed cepstral peak prominence measures, and global perceived change following the intervention. It is expected that the study will contribute to a better understanding of the effects of the intervention on vocal outcomes, supporting the optimization and standardization of therapeutic protocols for laryngeal dystonia.

Interventions

DEVICEActive rTMS

Active repetitive transcranial magnetic stimulation (rTMS) delivered using a magnetic stimulator according to the study protocol.

DEVICESham rTMS

Sham repetitive transcranial magnetic stimulation (rTMS) delivered using a sham stimulation procedure designed to mimic active rTMS without delivering therapeutic magnetic stimulation.

Standardized speech-language therapy focused on voice rehabilitation delivered by a licensed speech-language pathologist according to the study protocol.

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Participants, care providers, and outcome assessors will be blinded to intervention condition (active vs sham).

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Adults (≥18 years) of any sex with a confirmed diagnosis of laryngeal dystonia * Participants not undergoing botulinum toxin treatment at the time of the intervention * Ability to provide informed consent * Ability to complete all study assessments and intervention procedures

Exclusion criteria

* Other forms of dystonia * Vocal fold lesions * Vocal fold paralysis * Contraindications to repetitive transcranial magnetic stimulation (rTMS) * Inability to complete study assessments or intervention procedures

Design outcomes

Primary

MeasureTime frameDescription
Acoustic Voice Parameters Assessed Using VoxMetria® and FonoView® Softwarethrough study completion, an average of 6 monthsAcoustic voice parameters will be assessed using VoxMetria and FonoView software during sustained vowel phonation and connected speech tasks. The analysis will include F0 standard deviation (F0 SD), F0 variability, semitone variability, jitter, cepstral peak prominence smoothed (CPPS), voiced time, and unvoiced time. Each parameter will be analyzed separately and reported as the change from baseline to post-intervention.

Secondary

MeasureTime frameDescription
Vocal Effort Assessed by the Borg Category Ratio 10 Scale for Vocal Effortthrough study completion, an average of 6 monthsVocal effort will be assessed using the Borg Category Ratio 10 Scale for Vocal Effort. Scores range from 0 to 10, where 0 indicates no vocal effort and 10 indicates maximum vocal effort. Higher scores indicate worse perceived vocal effort.
Patient Global Impression of Change Assessed by the Patient Global Impression of Change Scalethrough study completion, an average of 6 monthsGlobal perceived change will be assessed using the Patient Global Impression of Change Scale. Scores range from 1 to 7, where 1 = very much worse and 7 = very much improved. Higher scores indicate greater perceived improvement.
Voice-Related Quality of Life Assessed by the Voice-Related Quality of Life Questionnaire (Brazilian Portuguese Version - QVV)through study completion, an average of 6 monthsVoice-related quality of life will be assessed using the Voice-Related Quality of Life (V-RQOL) questionnaire, validated for Brazilian Portuguese (QVV). Scores range from 0 to 100, with higher scores indicating better voice-related quality of life.

Contacts

CONTACTKatia K Monte-Silva
monte.silva@ufpe.br+55(81) 99503-2493
PRINCIPAL_INVESTIGATORNathália Suellen Valeriano Cardoso Cardoso

UFPE - nathalia.suellen@ufpe.br

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026